Identification of erythroferrone as an erythroid regulator of iron metabolism

Cited by (1,000)

Items 301–400 of 1,000

  1. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
    Jolanta Małyszko, Jacek Stanisław Małyszko, Joanna Matuszkiewicz‐Rowińska · 2019 · Expert Opinion on Therapeutic Targets
  2. Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections?
    Rafiou Agoro, Catherine Mura · 2019 · Pharmaceuticals
  3. Brain Iron Metabolism and Regulation
    Peng Yu, Yan‐Zhong Chang · 2019 · Advances in experimental medicine and biology
  4. Lactoferrin: from the structure to the functional orchestration of iron homeostasis
    Giusi Ianiro, Luigi Rosa, Maria Carmela Bonaccorsi di Patti, Piera Valenti, Giovanni Musci, Antimo Cutone · 2022 · BioMetals
  5. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies
    Heather A. Leitch, Eitan Fibach, Eliezer A. Rachmilewitz · 2017 · Critical Reviews in Oncology/Hematology
  6. Iron metabolism in critically ill patients developing anemia of inflammation: a case control study
    Boshuizen, Margit, Binnekade, Jan M., Nota, Benjamin, van de Groep, Kirsten, Cremer, Olaf L., Tuinman, Pieter R., Horn, Janneke, Schultz, Marcus J., van Bruggen, Robin, Juffermans, Nicole P. et al. · 2018 · Annals of Intensive Care
  7. How I treat non-transfusion-dependent β-thalassemia
    Antoine N. Saliba, Khaled M. Musallam, Ali T. Taher · 2023 · Blood
  8. Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia
    Maciej Garbowski, Manuel Ugidos, Alberto Risueño, Jeevan K. Shetty, Martin Schwickart, Olivier Hermine, John B. Porter, Anjan Thakurta, Sadanand Vodala · 2023 · American Journal of Hematology
  9. Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis
    Alessandro Mattè, Luigia De Falco, Enrica Federti, Anna Cozzi, Achille Iolascon, Sonia Levi, Narla Mohandas, Alberto Zamò, Mariasole Bruno, Christophe Lebœuf et al. · 2017 · Antioxidants and Redox Signaling
  10. Iron attenuates erythropoietin production by decreasing hypoxia-inducible transcription factor 2α concentrations in renal interstitial fibroblasts
    Norio Suzuki, Yukari Matsuo-Tezuka, Yusuke Sasaki, Koji Sato, Kenichiro Miyauchi, Koichiro Kato, Sakae Saito, Yasushi Shimonaka, Michinori Hirata, Masayuki P. Yamamoto · 2018 · Kidney International
  11. Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells
    Pandur, Edina, Tamási, Kitti, Pap, Ramóna, Varga, Edit, Miseta, Attila, Sipos, Katalin · 2019 · Cellular and Molecular Neurobiology
  12. Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions
    Allison L. Fisher, Jodie L. Babitt · 2021 · Developmental Dynamics
  13. Novel Therapeutic Advances in β-Thalassemia
    Alexandros C. Makis, Ersi Voskaridou, Ioannis Papassotiriou, Eleftheria ChR. Hatzimichael · 2021 · Biology
  14. Iron Deficiency Anaemia and Iron Overload
    Mark Worwood, Alison M. May, Barbara Jane Bain · 2017 · Elsevier eBooks
  15. Iron as a therapeutic target in chronic liver disease
    Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki · 2023 · World Journal of Gastroenterology
  16. Hepcidin as a new biomarker for detecting autologous blood transfusion
    Nicolas Leuenberger, Laura Barras, Raul Nicoli, Neil Robinson, Norbert Baume, Niels Lion, Stefano Barelli, Jean‐Daniel Tissot, Martial Saugy · 2016 · American Journal of Hematology
  17. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity
    Margit Boshuizen, Koen van der Ploeg, Leni von Bonsdorff, Bart J. Biemond, Sacha Sergio Zeerleder, Robin van Bruggen, Nicole Petra Juffermans · 2017 · Blood Reviews
  18. Green tea activity and iron overload induced molecular fibrogenesis of rat liver
    Gadah Ibraheem Albasher · 2017 · Saudi Journal of Biological Sciences
  19. Leukemia inhibitory factor regulates Schwann cell proliferation and migration and affects peripheral nerve regeneration
    Qianqian Chen, Qianyan Liu, Yunsong Zhang, Shiying Li, Sheng Yi · 2021 · Cell Death and Disease
  20. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice
    Xiaoyu Wang, Mingzhen Zhang, Regina R. Woloshun, Yang Yu, Jennifer K. Lee, Shireen RL Flores, Didier Merlin, James F. Collins · 2021 · Nutrients
  21. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice
    Richard Coffey, Grace Jung, Joseph D. Olivera, Gabriel Karin, Renata C. Pereira, Elizabeta Nemeth, Tomas Ganz · 2021 · Blood
  22. Iron Absorption: Molecular and Pathophysiological Aspects
    Margherita Correnti, Elena Gammella, Gaetano Cairo, Stefania Recalcati · 2024 · Metabolites
  23. Hematopoietic niches, erythropoiesis and anemia of chronic infection
    Ana Cordeiro Gomes, Maria Salomé Gomes · 2015 · Experimental Hematology
  24. Diagnosing and preventing iron overload
    Ganesh Ramanathan, John Kevin Olynyk, Paolo Ferrari · 2017 · Hemodialysis International
  25. Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone
    Mark R. Hanudel, Shirley Fitzpatrick Wong, Grace Jung, Bo Qiao, Victoria R. Gabayan, Anna Zuk, Tomas Ganz · 2021 · Kidney International
  26. Hepcidin and Iron Metabolism in Experimental Liver Injury
    Steven A. Bloomer, Kyle E. Brown · 2021 · American Journal Of Pathology
  27. Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients—The Debate Is Still Open
    Jagoda Kruszewska, Hanna Laudy-Wiaderny, Michał Kunicki · 2022 · International Journal of Environmental Research and Public Health
  28. Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease
    Schaefer, Benedikt, Haschka, David, Finkenstedt, Armin, Petersen, Britt-Sabina, Theurl, Igor, Henninger, Benjamin, Janecke, Andreas R., Wang, Chia-Yu, Lin, Herbert Y., Veits, Lothar et al. · 2015 · Human Molecular Genetics
  29. Normal and dysregulated crosstalk between iron metabolism and erythropoiesis
    Yelena Z. Ginzburg, Xiuli An, Stefano Rivella, Adam N. Goldfarb · 2023 · eLife
  30. Erythropoiesis-stimulating Agents in Critically Ill Trauma Patients
    Craig French, Neil J. Glassford, Dashiell C. Gantner, Alisa M. Higgins, David James Cooper, Alistair Nichol, Markus B. Skrifvars, Georgina LL Imberger, Jeffrey Presneill, Michael Bailey et al. · 2016 · Annals of Surgery
  31. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
    Sandrine Gaillard, Andreas H. Bock, Fernando Carrera, Kai‐Uwe Eckardt, David B. Van Wyck, Sukhvinder S. Bansal, Maureen Cronin, Yvonne Meier, Sylvain Larroque, Simon D. Roger et al. · 2016 · PLoS ONE
  32. Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations
    Guy Rostoker, Nosratola D. Vaziri · 2019 · Heliyon
  33. Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis
    Stephen R. Hennigar, Claire E. Berryman, Melissa Nauta Harris, James Philip Karl, Harris R. Lieberman, James P. McClung, Jennifer Carlton Rood, Stefan M. Pasiakos · 2020 · The Journal of Clinical Endocrinology & Metabolism
  34. The benefits of iron supplementation following blood donation vary with baseline iron status
    Alan E. Mast, Anikó Szabó, Mars Stone, Ritchard G. Cable, Bryan R. Spencer, Joseph E. Kiss, for the NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)‐III · 2020 · American Journal of Hematology
  35. Regulation of iron homeostasis: Lessons from mouse models
    Sandro Altamura, Oriana Marques, Silvia Colucci, Christina Mertens, Kristina Alikhanyan, Martina Ulrike Muckenthaler · 2020 · Molecular Aspects of Medicine
  36. Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
    Guillaume Courbon, Jane Joy Thomas, Marta Martínez‐Calle, Xueyan Wang, Jadeah Jeannine Spindler, John C. Von Drasek, Bridget Hunt-Tobey, Rupal C. Mehta, Tamara Isakova, Wenhan Chang et al. · 2023 · Blood
  37. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia
    Yumei Huang, Lei Yu, Rongrong Liu, Jiaodi Liu, Gaohui Yang, Zhifu Xiang, Yuzhen Liang, Yongrong Lai · 2019 · International Journal of Medical Sciences
  38. Iron Deficiency, Anemia, and the Immune System
    Anna‐Maria Mitterstiller, Laura von Raffay, Manfred Nairz · 2022 · Nutrition and health
  39. Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis
    Gregg L. Semenza · 2021 · Blood
  40. The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling
    Ugo Sardo, Prunelle Perrier, Kévin Cormier, Manon Sotin, Jean Personnaz, Thanina Medjbeur, Aurore Desquesnes, Lisa Cannizzo, Marc Ruíz-Martínez, Julie Thevenin et al. · 2024 · Blood
  41. Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease
    Matthew S. Karafin, Kathryn L. Koch, Amy B. Rankin, Debora Nischik, Ghady Rahhal, Pippa Margaret Simpson, Joshua J. Field · 2015 · Blood Cells Molecules and Diseases
  42. Imatinib and spironolactone suppress hepcidin expression
    Katarzyna Mleczko‐Sanecka, Ana Rita da Silva, Debora Call, Joana Camões Neves, Nikolai Schmeer, Georg Damm, Daniel Seehofer, Martina Ulrike Muckenthaler · 2017 · Haematologica
  43. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
    Cornel S. G. Mirciov, Sarah J. Wilkins, Grace Ching Ching Hung, Sheridan L. Helman, Gregory Jon Anderson, David Michael Frazer · 2018 · Haematologica
  44. Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer
    Thiago Gagliano‐Jucá, Karol Mateusz Pencina, Tomas Ganz, Thomas G. Travison, Philip W. Kantoff, Paul Linh Nguyen, Mary‐Ellen Taplin, Adam Stuart Kibel, Zhuoying Li, Grace Tzu-Wei Huang et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
  45. Molecular perspective of iron uptake, related diseases, and treatments
    Negin Shokrgozar, Habibollah Golafshan · 2019 · Blood Research
  46. Ferroptosis As Ultimate Target of Cancer Therapy
    Yashiro Motooka, Shinya Toyokuni · 2022 · Antioxidants and Redox Signaling
  47. Investigational therapies for renal disease-induced anemia
    Holger Schmid, WOLFGANG E. B. JELKMANN · 2016 · Expert Opinion on Investigational Drugs
  48. Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion
    Flaminia Cavallaro, Lorena Duca, Laura Francesca Pisani, Roberta Rigolini, Luisa Spina, Gian Eugenio Tontini, Nadia Munizio, Elena Costa, Maria Domenica Cappellini, Maurizio Li Vecchi et al. · 2017 · Canadian Journal of Gastroenterology and Hepatology
  49. Clinical Implications of New Insights into Hepcidin-Mediated Regulation of Iron Absorption and Metabolism
    Andrew M. Prentice · 2017 · Annals of Nutrition and Metabolism
  50. Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia
    Fady M. El Gendy, Mahmoud A. El‐Hawy, Amira M.F. Shehata, Hanaa E. Osheba · 2017 · European Journal Of Haematology
  51. Association of Serum Hepcidin Levels with Aerobic and Resistance Exercise: A Systematic Review
    Phureephat Larsuphrom, Gladys Oluyemisi Latunde-Dada · 2021 · Nutrients
  52. Supra-Carbon Dots Formed by Fe3+-Driven Assembly for Enhanced Tumor-Specific Photo-Mediated and Chemodynamic Synergistic Therapy
    Qiao Chen, Shan Sun, Hengwei Lin, Zhongjun Li, Aiguo Wu, Xiaohong Liu, Fu‐Gen Wu, Wei Zhang · 2021 · ACS Applied Bio Materials
  53. Iron and oxygen sensing: a tale of 2 interacting elements?
    Robert James Simpson, Andrew Tristan McKie · 2014 · Metallomics
  54. Signaling Integration of Hydrogen Sulfide and Iron on Cellular Functions
    Hassan Mustafa Arif, Zhong‐Ming Qian, Rui Wang · 2021 · Antioxidants and Redox Signaling
  55. Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone
    Chiara Maura Ciniselli, Maida De Bortoli, Elena Taverna, Luca Varinelli, Sara Pizzamiglio, Silvia Veneroni, Chiara Bonini, Rosaria Orlandi, Paolo Verderio, Italia Bongarzone · 2015 · Expert Review of Proteomics
  56. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors
    Sara Pizzamiglio, Maida De Bortoli, Elena Taverna, Michele Signore, Silvia Veneroni, William Cho, Rosaria Orlandi, Paolo Verderio, Italia Bongarzone · 2017 · International Journal of Molecular Sciences
  57. Interplay of adipocyte and hepatocyte: Leptin upregulates hepcidin
    Kiyoko Yamazaki Yamamoto, Takahiro Kuragano, Tomoko Kimura, Masayoshi Nanami, Yukiko Hasuike, Takeshi Nakanishi · 2017 · Biochemical and Biophysical Research Communications
  58. Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice
    Chia‐Yu Wang, Susanna Canali, Abraham L. Bayer, Som Dev, Aneesh Agarwal, Jodie L. Babitt · 2018 · American Journal of Hematology
  59. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model
    Artuso, Irene, Lidonnici, Maria Rosa, Altamura, Sandro, Mandelli, Giacomo, Pettinato, Mariateresa, Muckenthaler, Martina U., Silvestri, Laura, Ferrari, Giuliana, Camaschella, Clara, Nai, Antonella · 2018 · Blood
  60. Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis
    Yi Sun, Yu Ren, Liyun Song, Yin-ying Wang, Tiangang Li, Yingli Wu, Li Li, Zhongshan Yang · 2024 · Biomedicine & Pharmacotherapy
  61. Iron therapy in chronic kidney disease: Recent changes, benefits and risks
    Sandra Ribeiro, Luı́s Belo, Flávio Reis, Alice Santos‐Silva · 2015 · Blood Reviews
  62. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction
    Daniel F. Wallace, Eriza S. Secondes, Gautam Rishi, Lesa Ostini, Cameron J. McDonald, Steven Lane, Therese Vu, John David Hooper, Gloria Velasco, Andrew J. Ramsay et al. · 2014 · British Journal of Haematology
  63. Icariin regulates systemic iron metabolism by increasing hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling
    Miao Zhang, Jing Liu, Wenli Guo, Xin Liu, Sijin Liu, Hui-jun Yin · 2016 · International Journal of Molecular Medicine
  64. Carbon Nanotubes Disrupt Iron Homeostasis and Induce Anemia of Inflammation through Inflammatory Pathway as a Secondary Effect Distant to Their Portal‐of‐Entry
    Juan Ma, Ruibin Li, Yin Liu, Guangbo Qu, Jing L. Liu, Wenli Guo, Haoyang Song, Xinghong Li, Yajun Liu, Tian Xia et al. · 2017 · Small
  65. The relationship between systemic iron homeostasis and erythropoiesis
    Gautam Rishi, V. Nathan Subramaniam · 2017 · Bioscience Reports
  66. Does Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?
    Inês S. da Silva, Vanessa Rausch, Helmut Karl Seitz, Sebastian Mueller · 2017 · Cancers
  67. Non-Classical Effects of FGF23: Molecular and Clinical Features
    Luis Martínez-Heredia, Juan Manuel Canelo Moreno, Beatriz García-Fontana, Manuel Muñoz‐Torres · 2024 · International Journal of Molecular Sciences
  68. Morbidities in non‐transfusion‐dependent thalassemia
    Antoine N. Saliba, Ali T. Taher · 2016 · Annals of the New York Academy of Sciences
  69. Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II
    Roberta Russo, Immacolata Andolfo, Francesco Manna, Gianluca De Rosa, Luigia De Falco, Antonella Gambale, Mariasole Bruno, Alessandro Mattè, Paolo Ricchi, Domenico Girelli et al. · 2016 · Blood
  70. Erythroferrone and matriptase‐2 independently regulate hepcidin expression
    Sharraya Aschemeyer, Victoria R. Gabayan, Tomas Ganz, Elizabeta Nemeth, Léon Kautz · 2017 · American Journal of Hematology
  71. Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model
    Naveen Kumar Tangudu, Betül Alan, Francesca Vinchi, Katharina Wörle, Dilay Lai, Sabine Vettorazzi, Kerstin Leopold, Maja Vujić Spasić · 2017 · Antioxidants and Redox Signaling
  72. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice
    Richard Coffey, Ugo Sardo, Léon Kautz, Victoria R. Gabayan, Elizabeta Nemeth, Tomas Ganz · 2018 · Physiological Reports
  73. Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD
    Rebecca Womack, Fabian N. Berru, Bhupesh Panwar, Orlando M. Gutiérrez · 2020 · Clinical Journal of the American Society of Nephrology
  74. Impact of bacterial infections on erythropoiesis
    Lara Valente de Souza, Alexander Hoffmann, Günter Weiß · 2020 · Expert Review of Anti-infective Therapy
  75. The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model
    Megan L. Noonan, Pu Ni, Rafiou Agoro, Spencer A. Sacks, Elizabeth A. Swallow, Jonathan A. Wheeler, Erica L. Clinkenbeard, Maegan L. Capitano, Matthew Prideaux, Gerald J. Atkins et al. · 2020 · Journal of Bone and Mineral Research
  76. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry
    Melanie Wendy Castro-Mollo, Sakshi Gera, Marc Ruíz-Martínez, Maria Feola, Anisa Azatovna Gumerova, Marina Planoutene, Cara Clementelli, Veena Sangkhae, Carla Casu, Se‐Min Kim et al. · 2021 · eLife
  77. RAP‐011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice
    Jacqueline M. Langdon, Sangjucta Barkataki, Alan E. Berger, Chris Cheadle, Qian‐Li Xue, Victoria Sung, Cindy N. Roy · 2014 · American Journal of Hematology
  78. Iron, oxygen, and the pulmonary circulation
    Matthew C. Frise, Peter A. Robbins · 2015 · Journal of Applied Physiology
  79. Iron overload in patients with myelodysplastic syndromes: An updated overview
    Nour M. Moukalled, Fuad A. El Rassi, Sally Naji Temraz, Ali T. Taher · 2018 · Cancer
  80. An intensified training schedule in recreational male runners is associated with increases in erythropoiesis and inflammation and a net reduction in plasma hepcidin
    Diego Moretti, Samuel Mettler, Christophe Zeder, Carsten Lundby, Anneke J Geurts-Moespot, Arnaud Monnard, Dorine W. Swinkels, Gary M. Brittenham, Michael Bruce Zimmermann · 2018 · American Journal of Clinical Nutrition
  81. Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections
    Kelvin M. Abuga, Manfred Nairz, Calman Alexander MacLennan, Sarah Helen Atkinson · 2023 · Wellcome Open Research
  82. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and -thalassemia intermedia
    Raffaella Origa, Mario Cazzola, Elisabetta Mereu, Fabrice Danjou, Susanna Barella, Nicolina Giagu, Renzo Galanello, Dorine W. Swinkels · 2015 · Haematologica
  83. Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver
    Sioḃán Keel, Raymond T. Doty, Li Liu, Elizabeta Nemeth, Sindhu Cherian, Tomas Ganz, Janis L. Abkowitz · 2015 · Experimental Hematology
  84. Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis
    Richard E. Holman, John Kevin Olynyk, Hemant Kulkarni, Paolo Ferrari · 2016 · Nephrology
  85. Mechanisms and Regulation of Intestinal Iron Transport
    James F. Collins, Shireen RL Flores, Xiaoyu Wang, Gregory Jon Anderson · 2018 · Elsevier eBooks
  86. Too much iron: A masked foe for leukemias
    Éolia Brissot, Delphine G. Bernard, Olivier Loréal, Pierre Brissot, Marie‐Bérengère Troadec · 2019 · Blood Reviews
  87. The mutual crosstalk between iron and erythropoiesis
    Clara Camaschella, Alessia Pagani, Laura Silvestri, Antonella Nai · 2022 · International Journal of Hematology
  88. Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis
    Sebastian Mueller, Cheng Chen, Johannes H. Mueller, Shijin Wang · 2022 · Journal of Translational Internal Medicine
  89. Thalassaemia in children: from quality of care to quality of life
    Ali Amid, Antoine N. Saliba, Ali T. Taher, Robert J. Klaassen · 2015 · Archives of Disease in Childhood
  90. TfR2 links iron metabolism and erythropoiesis
    Kostas Pantopoulos · 2015 · Blood
  91. Hepcidin: a real-time biomarker of iron need
    Dominic James Hare · 2017 · Metallomics
  92. Inter-organ signalling by HRG-7 promotes systemic haem homeostasis
    Jason W. Sinclair, Katherine L. Pinter, Tamika K. Samuel, Simon Beardsley, Xiaojing Yuan, Jianbing Zhang, Kevin Meng, Sijung Yun, Michael Krause, Iqbal Hamza · 2017 · Nature Cell Biology
  93. The interplay between iron and oxygen homeostasis with a particular focus on the heart
    Samira Lakhal‐Littleton, Peter A. Robbins · 2017 · Journal of Applied Physiology
  94. Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude
    Rebecca C. Hall, Peter Peeling, Elizabeta Nemeth, Dan Bergland, Walter T. P. McCluskey, Trent Stellingwerff · 2018 · Medicine & Science in Sports & Exercise
  95. Hepcidin and the Global Burden of Iron Deficiency
    Tomas Ganz · 2014 · Clinical Chemistry
  96. Evidence of relative iron deficiency in platelet‐ and plasma‐pheresis donors correlates with donation frequency
    Huihui Li, Frances Condon, Debra A. Kessler, Vijay Nandi, Mark Rebosa, Mark E. Westerman, Beth H. Shaz, Yelena Z. Ginzburg · 2016 · Journal of Clinical Apheresis
  97. 20 years of Hepcidin: How far we have come
    Silvia Colucci, Oriana Marques, Sandro Altamura · 2021 · Seminars in Hematology
  98. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development
    John B. Porter, Ali T. Taher, Vip Viprakasit, Antonis Kattamis, Thomas D. Coates, Maciej Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard, Maria Domenica Cappellini · 2021 · Expert Review of Hematology
  99. Nano-formulations in treatment of iron deficiency anaemia: An overview
    Kuldeep Singh, Dimple Sethi Chopra, Dhandeep Singh, Nirmal Singh · 2022 · Clinical Nutrition ESPEN
  100. Metabolic regulation of stress erythropoiesis, outstanding questions, and possible paradigms
    Baiye Ruan, Robert F. Paulson · 2023 · Frontiers in Physiology